Published in Cancer Cell Int on July 15, 2013
Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy. Springerplus (2015) 0.75
Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells. BMC Cancer (2016) 0.75
Establishment and characterization of a receptor-negative, hormone-nonresponsive breast cancer cell line from an Iraqi patient. Breast Cancer (Dove Med Press) (2015) 0.75
Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines. Drugs R D (2017) 0.75
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med (2009) 24.75
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med (1997) 13.96
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell (1996) 5.10
A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA (1995) 4.45
Genetic analysis of BRCA1 function in a defined tumor cell line. Mol Cell (1999) 3.83
BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med (1996) 3.83
Aberrant subcellular localization of BRCA1 in breast cancer. Science (1995) 3.61
Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet (1995) 3.61
Growth retardation and tumour inhibition by BRCA1. Nat Genet (1996) 3.47
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet (1995) 2.91
Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet (1999) 2.83
Role of mammalian Mre11 in classical and alternative nonhomologous end joining. Nat Struct Mol Biol (2009) 2.76
Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA (1998) 2.76
Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res (1998) 2.72
BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci U S A (2002) 1.89
Location of BRCA1 in human breast and ovarian cancer cells. Science (1996) 1.88
Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am J Hum Genet (1998) 1.75
Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriers. Cancer Res (2009) 1.66
The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon. Hum Mutat (2006) 1.58
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci U S A (1998) 1.53
Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer (2002) 1.44
Association of nonribosomal nucleolar proteins in ribonucleoprotein complexes during interphase and mitosis. Mol Biol Cell (1999) 1.43
Expression of BRCA1 protein in breast cancer and its prognostic significance. Hum Pathol (2008) 1.40
Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies. Mol Cancer Res (2009) 1.37
Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer. Cancer Res (2000) 1.29
Synthetic lethal approaches to breast cancer therapy. Nat Rev Clin Oncol (2010) 1.17
Phosphorylated BRCA1 is predominantly located in the nucleus and mitochondria. Mol Biol Cell (2004) 1.09
Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer. Clin Cancer Res (1995) 1.08
Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors. Biochem Biophys Res Commun (1998) 1.03
Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers. Int J Cancer (1998) 1.01
Loss of heterozygosity in familial breast carcinomas. Cancer Res (1993) 1.00
BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines. Am J Pathol (2010) 0.97
Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype. Cancer Genet Cytogenet (1998) 0.96
Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene. Int J Cancer (1999) 0.95
Methylation of the tumor suppressor protein, BRCA1, influences its transcriptional cofactor function. PLoS One (2010) 0.94
The usefulness of antibodies to the BRCA1 protein in detecting the mutated BRCA1 gene. An immunohistochemical study. J Clin Pathol (2001) 0.91
Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2. Cancer Res (2002) 0.90
Loss of nuclear BRCA1 localization in breast carcinoma is age dependent. Virchows Arch (2001) 0.85
The BRCA1 Breast Cancer Suppressor: Regulation of Transport, Dynamics, and Function at Multiple Subcellular Locations. Scientifica (Cairo) (2012) 0.85
Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours. Virchows Arch (2013) 0.84
BRCA1 185delAG mutant protein, BRAt, up-regulates maspin in ovarian epithelial cells. Gynecol Oncol (2009) 0.83
Recommendations for the reporting of breast carcinoma. Association of Directors of Anatomic and Surgical Pathology. Mod Pathol (1996) 0.82
Quantitative analysis of BRCA1 and BRCA2 mRNA expression in sporadic breast carcinomas and its relationship with clinicopathological characteristics. Jpn J Cancer Res (2001) 0.81
Nucleolar exit of RNF8 and BRCA1 in response to DNA damage. Exp Cell Res (2012) 0.80
Localization of BRCA1 protein in human breast cancer cells. Breast Cancer Res Treat (2003) 0.78
Nucleolar localization of BRCA1 protein in human breast cancer. Int J Oncol (1998) 0.78
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med (2003) 4.64
The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology (2003) 3.87
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology (2007) 3.39
Adding emotional stressors to training in simulated cardiopulmonary arrest enhances participant performance. Med Educ (2010) 3.17
Weekly versus basic smoking cessation support in primary care: a randomised controlled trial. Thorax (2007) 2.86
Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet (2003) 2.81
How time affects the risk of rupture in appendicitis. J Am Coll Surg (2006) 2.71
The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease. Neurology (2013) 2.64
Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases. Hum Mutat (2010) 2.29
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol (2008) 2.16
Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int (2002) 2.15
Reversible coma in children after improper baclofen pump insertion. Paediatr Anaesth (2002) 2.02
Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations. Am J Hum Genet (2008) 1.99
Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res (2010) 1.89
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest (2011) 1.89
The consequence of multiple re-excisions to obtain clear lumpectomy margins in breast cancer patients. Ann Surg Oncol (2005) 1.87
Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol (2002) 1.86
Mutation in Rpa1 results in defective DNA double-strand break repair, chromosomal instability and cancer in mice. Nat Genet (2005) 1.84
Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and hashimoto's thyroiditis: A stem cell hypothesis of papillary carcinoma oncogenesis. Hum Pathol (2004) 1.83
Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res (2010) 1.82
Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups. Pharmacogenomics (2010) 1.82
Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine. Clin Gastroenterol Hepatol (2005) 1.79
An atypical deletion of the Williams-Beuren syndrome interval implicates genes associated with defective visuospatial processing and autism. J Med Genet (2006) 1.78
Resveratrol in human cancer chemoprevention--choosing the 'right' dose. Mol Nutr Food Res (2011) 1.77
What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One (2011) 1.74
The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol (2004) 1.74
Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol (2006) 1.73
Take note(s): differential EHR satisfaction with two implementations under one roof. J Am Med Inform Assoc (2003) 1.73
Predictors of nonsentinel lymph node metastasis in breast cancer patients. Am J Surg (2002) 1.69
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342. Breast Cancer Res (2006) 1.69
Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol (2006) 1.69
Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiol Biomarkers Prev (2002) 1.68
Clinical trials of resveratrol. Ann N Y Acad Sci (2011) 1.66
Epithelial displacement in breast lesions: a papillary phenomenon. Arch Pathol Lab Med (2005) 1.64
Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining. Clin J Am Soc Nephrol (2007) 1.64
Use of PER977 to reverse the anticoagulant effect of edoxaban. N Engl J Med (2014) 1.57
Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine. Clin Gastroenterol Hepatol (2008) 1.57
PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol Cell Biol (2011) 1.52
Premarital and prenatal screening for cystic fibrosis: experience in the Ashkenazi Jewish population. Genet Med (2004) 1.52
Pilot study of oral anthocyanins for colorectal cancer chemoprevention. Cancer Prev Res (Phila) (2009) 1.50
Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol (2004) 1.50
p53 acetylation is crucial for its transcription-independent proapoptotic functions. J Biol Chem (2009) 1.48
Optimizing selective cerebral perfusion: deleterious effects of high perfusion pressures. J Thorac Cardiovasc Surg (2008) 1.48
The fate of the distal aorta after repair of acute type A aortic dissection. J Thorac Cardiovasc Surg (2006) 1.47
Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology (2005) 1.44
BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays. Am J Surg Pathol (2007) 1.43
Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center. Ann Thorac Surg (2004) 1.43
Correspondence regarding M. Sharma et al., "Antioxidant inhibits tamoxifen-DNA adducts in endometrial explant culture". Biochem Biophys Res Commun (2003) 1.41
Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer. Support Care Cancer (2007) 1.40
Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver. Hum Gene Ther (2006) 1.39
CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing. Pharmacogenomics (2009) 1.37
T-cell PTLD presenting as acalculous cholecystitis. Pediatr Transplant (2008) 1.37
Cell-graph mining for breast tissue modeling and classification. Conf Proc IEEE Eng Med Biol Soc (2007) 1.35
Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial. Genet Test (2008) 1.31
Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials. Cancer Prev Res (Phila) (2009) 1.31
Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization. Mov Disord (2010) 1.31
Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction. Health Psychol (2009) 1.30
Detection of low-level mosaicism and placental mosaicism by oligonucleotide array comparative genomic hybridization. Genet Med (2010) 1.27
Analytical validation of whole exome and whole genome sequencing for clinical applications. BMC Med Genomics (2014) 1.27
Type 1 Gaucher disease: significant disease manifestations in "asymptomatic" homozygotes. Arch Intern Med (2010) 1.25
Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am J Hematol (2002) 1.24
Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results. Am J Med Genet C Semin Med Genet (2006) 1.21
Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation. J Biol Chem (2012) 1.21
Loss of polycystin-1 causes centrosome amplification and genomic instability. Hum Mol Genet (2008) 1.20
An audit of results of a no-drainage practice policy after hepatectomy. Am J Surg (2002) 1.20
Extubation in the operating room after congenital heart surgery in children. J Thorac Cardiovasc Surg (2008) 1.18
N-cadherin expression in breast cancer: correlation with an aggressive histologic variant--invasive micropapillary carcinoma. Breast Cancer Res Treat (2005) 1.16
Renal gene and protein expression signatures for prediction of kidney disease progression. Am J Pathol (2009) 1.15
Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT. BMC Med Genomics (2008) 1.15
Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma. Am J Surg Pathol (2010) 1.15
DNA synthesis is required for reprogramming mediated by stem cell fusion. Cell (2013) 1.14
A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors. Clin Cancer Res (2008) 1.12
Composite aortic root replacement in acute type A dissection: time to rethink the indications? Eur J Cardiothorac Surg (2005) 1.12
Effect of copy number variants on outcomes for infants with single ventricle heart defects. Circ Cardiovasc Genet (2013) 1.11
Histopathology of renal failure after heart transplantation: a diverse spectrum. J Heart Lung Transplant (2011) 1.10
Intestinal trefoil factor: a marker of poor prognosis in gastric carcinoma. Clin Cancer Res (2002) 1.10
A herpes oncolytic virus can be delivered via the vasculature to produce biologic changes in human colorectal cancer. Mol Ther (2008) 1.09
Preoperative arterial pulse pressure has no apparent association with perioperative mortality after lower extremity arterial bypass. Anesth Analg (2011) 1.09
Risk of Buruli ulcer and detection of Mycobacterium ulcerans in mosquitoes in southeastern Australia. PLoS Negl Trop Dis (2011) 1.09
Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell Reprogram (2010) 1.08
Predictive model for postoperative delirium in cardiac surgical patients. Semin Cardiothorac Vasc Anesth (2010) 1.08
The variable pathology of kidney disease after liver transplantation. Transplantation (2010) 1.08
Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years. Clin Gastroenterol Hepatol (2008) 1.07
A case of autoimmune thyroiditis and membranoproliferative glomerulonephritis. Pediatr Nephrol (2007) 1.06
High-grade neuroendocrine carcinoma of the colon, long-term survival in advanced disease. Med Oncol (2010) 1.06
Can assessment for obstructive sleep apnea help predict postadenotonsillectomy respiratory complications? Anesthesiology (2002) 1.05
Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. J Surg Oncol (2002) 1.04
Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol (2007) 1.03
A large-scale survey of the novel 15q24 microdeletion syndrome in autism spectrum disorders identifies an atypical deletion that narrows the critical region. Mol Autism (2010) 1.03
Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial. Med Decis Making (2010) 1.03
Childhood sleep apnea and neighborhood disadvantage. J Pediatr (2010) 1.02
Modulation of agonist binding to human dopamine receptor subtypes by L-prolyl-L-leucyl-glycinamide and a peptidomimetic analog. J Pharmacol Exp Ther (2005) 1.01
Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence. Sci Transl Med (2013) 1.00
Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin. JACC Cardiovasc Imaging (2012) 1.00
Differential expression of profibrotic and growth factors in chronic allograft nephropathy. Transplantation (2006) 0.99